MTTlab and DTI-Tech have established a strategic collaboration integrating drug target identification, mechanism-of-action investigation and drug-resistance modelling with MTTlab’s preclinical research capabilities.
The collaboration creates opportunities to connect mechanistic investigation with functional validation and, where appropriate, in vivo translational proof of concept.